EVM
BSTG

Eaton Vance Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Eaton Vance Management’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,952
Closed -$12K – 1022
2016
Q3 		$12K Hold
10,952
– – ﹤0.01% 970
2016
Q2 		$12K Buy
+10,952
New +$17.7K ﹤0.01% 945
2016
Q1 		– Sell
-10,952
Closed -$24K – 966
2015
Q4 		$24K Buy
+10,952
New +$15.3K ﹤0.01% 937

Other funds holding BSTG

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eaton Vance Management's BSTG Position: Q4 2016 in Review

Eaton Vance Management sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2016, closing a stake of 10,952 shares — an estimated $12K sold.

Eaton Vance Management first reported a position in BSTG in Q4 2015 and held it in 3 quarters. The position peaked at $24K in Q4 2015. 27 funds tracked by Wall St. Rank hold BSTG as of Q4 2016.

  • Eaton Vance Management reported no remaining Biostage, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Eaton Vance Management sold 10,952 Biostage, Inc. Common Stock shares in Q4 2016, an estimated $12K.
  • Eaton Vance Management first reported a position in Biostage, Inc. Common Stock in Q4 2015 and held it in 3 quarters.
  • Eaton Vance Management's Biostage, Inc. Common Stock position peaked at $24K in Q4 2015.
  • 27 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2016.

Based on Eaton Vance Management's 13F filing for Q4 2016, filed 15 Feb 2017.